The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID mice
Authors:
- D R SørensenDSD R Sørensen
- Ge TjønnfjordGTGe Tjønnfjord
- C BeiskeCBC Beiske
- T-A HagveTHT-A Hagve
- He RugstadHRHe Rugstad
- Opf ClausenOCOpf Clausen
- 26 November 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (12) , 2388-2394
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 47 references indexed in Scilit:
- Human MDR 1 Protein Overexpression Delays the Apoptotic Cascade in Chinese Hamster Ovary FibroblastsBiochemistry, 1997
- Phosphatidylcholine and Phosphatidylethanolamine Behave as Substrates of the Human MDR1 P-GlycoproteinBiochemistry, 1997
- Functions of Ceramide in Coordinating Cellular Responses to StressScience, 1996
- Clinical trials of p-glycoprotein reversal in solid tumoursEuropean Journal of Cancer, 1996
- MDR1/P-glycoprotein in haematological neoplasmsEuropean Journal of Cancer, 1996
- Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoproteinCytometry, 1995
- Interleukin‐3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG‐01 cellsBritish Journal of Haematology, 1994
- Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin AEuropean Journal of Cancer and Clinical Oncology, 1991
- A Model of Human Acute Lymphoblastic Leukemia in Immune-Deficient SCID MiceScience, 1989
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987